A recent association between exposure to GLP-1R agonists and a reduced risk of glaucoma makes it even more justified to consider the neuroprotective potential of GLP-1R agonists, particularly semaglutide, in anti-glaucomatous treatment strategies
This guide is for research math only
CI: confidence interval Figure 1: Time to First Occurrence of a MACE in Trial 7 Data from the in-trial period based on full analysis set defined as all randomized patients
Individuals with measured HbA1c outcomes were randomly divided into a 60:40 ratio between the development (31,346 individuals) and validation (20,865 individuals) groups to build the one-year glycemic response therapy selection model
Every weight loss journey is different, and so are our customized treatment plans
Choose Physician Guided Alternatives At Pure Medical Spa , we focus on physician supervised weight loss using FDA-approved medications like Wegovy and Zepbound